Quick Answer
CYTOKINETICS INC reported Cash and Equivalents of $122.52 million for fiscal year 2025.
CYTOKINETICS INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $122.52M | +29.2% |
| 2024 | $94.86M | -16.1% |
| 2023 | $113.02M | +72.3% |
| 2022 | $65.58M | -41.8% |
| 2021 | $112.67M | +35.8% |
| 2020 | $82.98M | +127.8% |
| 2019 | $36.43M | -13.8% |
| 2018 | $42.26M | -66.3% |
| 2017 | $125.21M | +87.2% |
| 2016 | $66.87M | +2.8% |
| 2015 | $65.08M | +221.9% |
| 2014 | $20.21M | +0.3% |
| 2013 | $20.16M | +35.2% |
| 2012 | $14.91M | -20.8% |
| 2011 | $18.83M | +7.5% |
| 2010 | $17.51M | -31.5% |
| 2009 | $25.56M | -38.9% |
| 2008 | $41.82M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $225.47M | +380.9% | +200.9% |
| June 30, 2025 | $74.94M | -60.6% | +1.7% |
| March 31, 2025 | $73.68M | -38.6% | -22.3% |
| December 31, 2024 | $94.86M | -16.1% | +102.3% |
| September 30, 2024 | $46.89M | -53.0% | -75.3% |
| June 30, 2024 | $190.14M | +177.0% | +58.5% |
| March 31, 2024 | $119.98M | +18.1% | +6.2% |
| December 31, 2023 | $113.02M | +72.3% | +13.4% |
- CYTOKINETICS INC showed an increase of +29.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, CYTOKINETICS INC’s cash and equivalents has grown by 193.0% (from $41.82 million to $122.52 million).
- The most recent figure is from CYTOKINETICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: